Drug
20ml bolus of 0.5% ropivicaine
20ml bolus of 0.5% ropivicaine is a pharmaceutical drug with 3 clinical trials. Historical success rate of 50.0%.
Total Trials
3
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
50.0%
Based on 1 completed trials
Completion Rate
50%(1/2)
Active Trials
0(0%)
Results Posted
200%(2 trials)
Terminated
1(33%)
Phase Distribution
Ph not_applicable
3
100%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
33.3%
1 of 3 finished
Non-Completion Rate
66.7%
2 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Completed(1)
Terminated(2)
Detailed Status
Completed1
Withdrawn1
Terminated1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
50.0%
Most Advanced
N/A
Trials by Phase
N/A3 (100.0%)
Trials by Status
completed133%
withdrawn133%
terminated133%
Recent Activity
0 active trials
Showing 3 of 3
terminatednot_applicable
Single Shot vs Catheter Infraclavicular Brachial Plexus Block After Distal Radius Fracture Repair
NCT02744352
withdrawnnot_applicable
Single Shot Infraclavicular Brachial Plexus Block vs Local Infiltration After Wrist Arthroscopy Surgery
NCT02970097
completednot_applicable
Single Shot vs 24hr vs 48hr Continuous Adductor Canal Block After TKA
NCT02730728
Clinical Trials (3)
Showing 3 of 3 trials
NCT02744352Not Applicable
Single Shot vs Catheter Infraclavicular Brachial Plexus Block After Distal Radius Fracture Repair
NCT02970097Not Applicable
Single Shot Infraclavicular Brachial Plexus Block vs Local Infiltration After Wrist Arthroscopy Surgery
NCT02730728Not Applicable
Single Shot vs 24hr vs 48hr Continuous Adductor Canal Block After TKA
All 3 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 3